Enhanced oral bioavailability of isradipine via proniosomal systems

References

• Azmin MN, Florence AT, Handjani-Vila RM, Stuart JF, Vanlerberghe G, Whittaker JS. (1985). The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice. J Pharm Pharmacol, 37:237–242.
   PubMed Web of Science ®Google Scholar
• Baillie AJ, Florence AT, Hume LR, Muirhead GT, Rogerson A. (1985). The preparation and properties of niosomes–non-ionic surfactant vesicles. J Pharm Pharmacol, 37:863–868.
   PubMed Web of Science ®Google Scholar
• Namdeo A, Jain NK. (1999). Niosomal delivery of 5-fluorouracil. J Microencapsul, 16:731–740.
   PubMed Web of Science ®Google Scholar
• Blazek-Welsh AI, Rhodes DG. (2001). SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes. Pharm Res, 18:656–661.
   PubMed Web of Science ®Google Scholar
• Prisant LM, Elliott WJ. (2003). Drug delivery systems for treatment of systemic hypertension. Clin Pharmacokinet, 42:931–940.
   PubMed Web of Science ®Google Scholar
• Fitton A, Benfield P. (1990). Isradipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs, 40:31–74.
   PubMed Web of Science ®Google Scholar
• Kim WC, Oh SH, Kim SH, Kim OJ, Lee MS. (2007). Parkinsonism and related disorders. Amsterdam BV: Elsevier Science, 113–140.
   Google Scholar
• Christensen HR, Antonsen K, Simonsen K, Lindekaer A, Bonde J, Angelo HR et al. (2000). Bioavailability and pharmacokinetics of isradipine after oral and intravenous administration: half-life shorter than expected? Pharmacol Toxicol, 86:178–182.
   PubMedGoogle Scholar
• Leroueil-Le Verger M, Fluckiger L, Kim YI, Hoffman M, Maincent P. (1998). Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur J Pharm Biopharm;46:137–143.
   PubMed Web of Science ®Google Scholar
• Tran TT, Tran PH, Choi HG, Han HK, Lee BJ. (2010). The roles of acidifiers in solid dispersions and physical mixtures. Int J Pharm, 384:60–66.
   PubMed Web of Science ®Google Scholar
• Malaterre V, Ogorka J, Loggia N, Gurny R. (2009). Approach to design push-pull osmotic pumps. Int J Pharm, 376:56–62.
   PubMed Web of Science ®Google Scholar
• Song KH, Chung SJ, Shim CK. (2002). Preparation and evaluation of proliposomes containing salmon calcitonin. J Control Release, 84:27–37.
   PubMed Web of Science ®Google Scholar
• Staniforth JN. (1988). The science dosage form design. In: Aulton ME, ed. Pharmaceutics. Edinburgh: Churchill Livingstone, Longman group, 610–636.
   Google Scholar
• Carr RL. (1965). Evaluation flow properties of solids. Chem Eng, 72:163–68.
   Google Scholar
• Subheet J, Parijat J, Umamaheshwari RB, Jain NK. (2003). Transfersomes-A novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm,29:1013–1026.
   PubMed Web of Science ®Google Scholar
• Nagarsenker MS, Londhe VY, Nadkarni GD. (1999). Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery. Int J Pharm, 190:63–71.
   PubMed Web of Science ®Google Scholar
• Sammour OA, Hammad MA, Megrab NA, Zidan AS. (2006). Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS PharmSciTech, 7:E55.
   PubMed Web of Science ®Google Scholar
• Valleri M, Mura P, Maestrelli F, Cirri M, Ballerini R. (2004). Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm, 30:525–534.
   PubMed Web of Science ®Google Scholar
• Pradip KG, Rita JM, Manish LU, Rayasa SRM. (2006). Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability. AAPS Pharm Sci Tech, 7:E1–E5.
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. (1993). Liposome technology. 2nd ed. Boca Raton, FL: CRC Press.
   Google Scholar
• Paolino D, Cosco D, Muzzalupo R, Trapasso E, Picci N, Fresta M. (2008). Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm, 353:233–242.
   PubMed Web of Science ®Google Scholar
• McMullen TP, McElhaney RN. (1997). Differential scanning calorimetric studies of the interaction of cholesterol with distearoyl and dielaidoyl molecular species of phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine. Biochemistry, 36:4979–4986.
   PubMed Web of Science ®Google Scholar
• Devaraj GN, Parakh SR, Devraj R, Apte SS, Rao BR, Rambhau D. (2002). Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. J Colloid Interface Sci, 251:360–365.
   PubMed Web of Science ®Google Scholar
• Mura S, Pirot F, Manconi M, Falson F, Fadda AM. (2007). Liposomes and niosomes as potential carriers for dermal delivery of minoxidil. J Drug Target, 15:101–108.
   PubMed Web of Science ®Google Scholar
• Staniforth J. (2002). Powder flow. In: Aulton M, ed. The science of dosage form design, Pharmaceutics. Edinburgh :Churchill Livingstone, Longman group, 197–210.
   Google Scholar
• Varghese V, Vitta P, Bakshi V, Agarwal S, Pandey S. (2004). Niosomes of primaquine: effect of sorbitan esters (spans) on the vesicular physical characterstics. Indian Drugs, 41:101–103.
   Google Scholar
• Bhavana V, Ajay JK, Jain NK. (1998). Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Release;54:149–165.
   PubMed Web of Science ®Google Scholar
• Cornaire G, Woodley J, Hermann P, Cloarec A, Arellano C, Houin G. (2004). Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm, 278:119–131.
   PubMed Web of Science ®Google Scholar
• Al-Meshal AM. (1998). Oral administration of liposomes containing cyclosporine: a pharmacokinetic study. Int J Pharm, 168:163–168.
   Web of Science ®Google Scholar
• Arien A, Dupuy B. (1997). Encapsulation of calcitonin in liposomes depends on the vesicle preparation method. J Microencapsul, 14:753–760.
   PubMed Web of Science ®Google Scholar
• Potluri P, Betageri GV. (2006). Mixed-micellar proliposomal systems for enhanced oral delivery of progesterone. Drug Deliv, 13:227–232.
   PubMed Web of Science ®Google Scholar